 |
|
|
|
 |
|
|
|
| Article 1 to 9 out of 9 concerning University of Oxford
|
-
Agilent Technologies Tools Used to Derive New Type of Mouse Embryonic Stem Cell that Shares Key Features of Human Embryonic Stem
(07/30/2007)
Using a variety of Agilent Technologies genomics tools, researchers at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and the University of Oxford, U.K., have achieved a major milestone in ...
-
VASTox joins European research consortium to target the development of new treatments for cancer
(01/19/2007)
Research will focus on Cancer Stem Cells as target for new therapies
VASTox announced that it has become a partner in a new European consortium that will undertake research towards developing new treatments for cancer. The research programme, called Targeting Cancer Stem Cells for Therapy, will be backed by a EUR2 ...
-
VASTox begins stem cell therapy programme with funding from the UK department for trade and industry
(09/22/2006)
VASTox announced that it will begin a new proprietary drug discovery programme in the stem cell area. The new programme will be supported by grant funding from the UK Department of Trade and Industry (DTI) under the Technology Programme, which is ...
-
Scientists unlock more secrets of HIV and SARS
(05/16/2006)
UK scientists have cracked one of the key biological processes used by viruses such as HIV and SARS when they replicate according to a paper published in the journal Nature. Viruses are able to interfere with the host cell processes that our bodies ...
-
Next generation bioscience centres in Edinburgh, Nottingham and Oxord awarded £27M
(04/25/2006)
Three new centres for integrative systems biology, representing an investment of £27M, have been announced by the Biotechnology and Biological Sciences Research Council (BBSRC). This follows the successful launch of three centres last year. The new ...
-
Oxford Genome Sciences and University of Oxford to develop new clinical biomarkers for colorectal cancer
(04/13/2006)
OGeS joins consortium focused on the development of new personalised management of colorectal cancer
Oxford Genome Sciences (UK) Ltd (OGeS) announced that it has entered into collaboration with the Department of Clinical Pharmacology at the University of Oxford to discover new clinical biomarkers for colorectal cancer (CRC).The collaboration forms ...
-
Metal atom dictates the structure: new concept for the construction of enzyme inhibitors
(01/27/2006)
Complex natural products usually adopt precisely defined spatial structures that are of critical importance to their biological function. A substrate must fit precisely into the "pocket" of an enzyme in order to be converted. The same is true of ...
-
SEQUENOM Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property
(10/24/2005)
SEQUENOM, Inc. has acquired exclusive rights in certain countries including the United States, United Kingdom and other countries in Europe and elsewhere, to non-invasive prenatal diagnostic intellectual property from Isis Innovation Ltd., the ...
-
NIH Awards $4.2 Million Grant to Scientists at Scripps Research to Speed DNA Sequencing Technologies
(08/10/2005)
A team of scientists at The Scripps Research Institute in California and Oxford University in England have been awarded a $4.2 million five-year grant to conduct basic science aimed at speeding the rate at which the next generation of DNA sequencing ...
|
|
|
Top